Skip to main content
APVO logo

APVO · Aptevo Therapeutics Inc. · Executive Compensation

Track APVO — free
$0.40 -0.01 (-3.36%)
Market Cap
$1.43M
Shares
3.46M
Volume · Nov 20 95.64K Avg daily vol (3M) 130.94K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Marvin L. White $1,277,403
Jeffrey G. Lamothe $1,020,205
SoYoung Kwon $904,464
Fiscal 2019
Executive Total
Marvin L. White $974,052
Jeffrey G. Lamothe $641,192
Jane Gross $587,949
Fiscal 2018
Executive Total
Marvin L. White $1,104,819
Jeffrey G. Lamothe $691,987
Jane Gross $636,446

Executive changes

Person Change Filed
John E. Niederhuber Appointed 2026-02-03
Jeff Lamothe Appointed 2026-02-03
Jeff Lamothe Appointed 2026-02-03
Marvin L. White Appointed 2026-02-03
Marvin L. White
“Mr. White’s intention to resign was not because of any disagreement with management or the Board of Directors of the Company (the “Board”) on any matter relating to the Company’s operations, policies or practices.”
Retired 2026-02-03
Daphne Taylor Appointed 2023-03-07
Jeffrey G. Lamothe Appointed 2023-03-07
John Niederhuber, M.D. Appointed 2022-01-21
Jane Gross Resigned 2021-08-27

Leadership

Key facts CIK 1671584 CUSIP 03835L702 13F (30d) 14 filings 12 filers Visit website Investor relations